Literature DB >> 10397079

Phlebosclerosis of the colon with positive anti-centromere antibody.

T Kitamura1, M Kubo, T Nakanishi, H Fushimi, K Yoshikawa, N Taenaka, T Furukawa, T Tsujimura, M Kameyama.   

Abstract

A 56-year-old woman with symptoms of chronic bowel disease presented a peculiar calcification of the mesenteric vein of the ascending to transverse colon on barium enema study. The resected colon was hard and black. Histo-pathologic examinations demonstrated fibrous change of the colon with a calcified and hyaline-deposited mesenteric vein. No cell infiltration was observed. These findings were compatible with phlebosclerosis and also with systemic sclerosis. Positive anti-centromere antibody and Raynaud's phenomenon, hallmarks of a variant systemic sclerosis, the CREST syndrome were observed. We therefore speculated that the pathogenesis of the phlebosclerosis of the colon is related to the CREST syndrome.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10397079     DOI: 10.2169/internalmedicine.38.416

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  10 in total

1.  Asymptomatic chronic intestinal ischemia caused by idiopathic phlebosclerosis of mesenteric vein.

Authors:  Nobuhide Oshitani; Yoshiki Matsumura; Mizuki Kono; Akihiro Tamori; Kazuhide Higuchi; Takayuki Matsumoto; Shuichi Seki; Tetsuo Arakawa
Journal:  Dig Dis Sci       Date:  2002-12       Impact factor: 3.199

2.  Relationship between severity of venous calcifications and symptoms of phlebosclerotic colitis.

Authors:  Tsung-Shuo Yen; Chien-An Liu; Nai-Chi Chiu; Yi-You Chiou; Yi-Hong Chou; Cheng-Yen Chang
Journal:  World J Gastroenterol       Date:  2015-07-14       Impact factor: 5.742

3.  Involvement of herbal medicine as a cause of mesenteric phlebosclerosis: results from a large-scale nationwide survey.

Authors:  Seiji Shimizu; Taku Kobayashi; Hideo Tomioka; Kensei Ohtsu; Toshiyuki Matsui; Toshifumi Hibi
Journal:  J Gastroenterol       Date:  2016-05-24       Impact factor: 7.527

Review 4.  Idiopathic mesenteric phlebosclerosis associated with long-term use of medical liquor: two case reports and literature review.

Authors:  Fang Guo; Yu-Fen Zhou; Fan Zhang; Fei Yuan; Yao-Zong Yuan; Wei-Yan Yao
Journal:  World J Gastroenterol       Date:  2014-05-14       Impact factor: 5.742

5.  Idiopathic mesenteric phlebosclerosis: clinical and CT imaging characteristics.

Authors:  Jian Ding; Weiqiang Zhang; Lizhang Wang; Zefeng Zhu; Jia Wang; Jianbing Ma
Journal:  Quant Imaging Med Surg       Date:  2021-02

6.  Idiopathic mesenteric phlebosclerosis: one case report and systematic literature review of 240 cases.

Authors:  Jialiang Wang; Jun Shao; Helei Lu; Bingyi Wang; Ji Chen
Journal:  Am J Transl Res       Date:  2021-11-15       Impact factor: 4.060

7.  Total dosage of gardenia fruit used by patients with mesenteric phlebosclerosis.

Authors:  Yutaka Nagata; Tetsuo Watanabe; Kazuhiko Nagasaka; Masaaki Yamada; Masafumi Murai; Sunao Takeuchi; Mai Murase; Toshinori Yazaki; Takayuki Murase; Kenichi Komatsu; Machiko Kaizuka; Mika Sano; Koji Asano; Chikao Ando; Norihide Taniuchi
Journal:  BMC Complement Altern Med       Date:  2016-07-11       Impact factor: 3.659

8.  Phlebosclerotic colitis: an analysis of clinical and CT findings in 29 patients with long-term follow-up.

Authors:  Sheung-Fat Ko; Hong-Hwa Chen; Chung-Cheng Huang; Li-Han Lin; Shu-Hang Ng; Yi-Wei Lee
Journal:  Insights Imaging       Date:  2022-01-29

9.  Idiopathic mesenteric phlebosclerosis associated with long-term oral intake of geniposide.

Authors:  Yang Wen; You-Wei Chen; Ai-Hong Meng; Ming Zhao; Song-Hua Fang; Yan-Qing Ma
Journal:  World J Gastroenterol       Date:  2021-06-14       Impact factor: 5.742

10.  Right hemicolectomy for mesenteric phlebosclerosis potentially caused by long-term use of herbal medicine: A case report and literature review.

Authors:  Nobuaki Hoshino; Suguru Hasegawa; Koya Hida; Kenji Kawada; Yoshiharu Sakai
Journal:  Int J Surg Case Rep       Date:  2016-05-31
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.